Participated · Series B · Sep 2021

accuRx offers a collaborative communications platform that brings patients and their healthcare teams together, beginning with the National Health Service (NHS) in the UK. The software is used by 98% of GP practices in England and by a growing number of hospitals and community trusts. The company’s product enables existing health and care systems to deliver technology-enabled care and to improve communication between clinicians and patients. Leadership is led by CEO Jacob Haddad and CTO Laurence Bargery. The newly raised funds are intended to grow the team, enhance accuRx’s offering to GP practices and build products to enable expansion into secondary care. Accurx's core product is Chain SMS, a messaging app used by doctor surgeries to communicate with patients. Chain SMS supports nurses, administrative staff, practice managers and GPs for tasks such as sending advice, notifying normal results, and appointment reminders, with all communication saved back to patients' medical records. The company originally built datasets and tools to reduce inappropriate antibiotic use but pivoted to a broader clinical communication platform while keeping data and machine learning central to its approach. Chain SMS launched in February 2018 and is already in use by 20% of GP practices in England, up from close to zero at launch. Accurx was founded by Jacob Haddad and Laurence Bargery at Entrepreneur First in 2016 and remains focused on improving healthcare delivery through tighter patient-team communication. Financially, the company has just closed an £8.8M Series A led by Atomico.

Participated · Series A · Jul 2014

Founded in 2013, Admedo offers a programmatic advertising platform that enables advertisers and agencies to run display and retargeting campaigns. The company also provides a white-label platform that agencies can deploy under their own brand. Headquartered in London, Admedo maintains additional offices in New York, Los Angeles, Berlin and Paris, and plans to add a Dubai office. In April 2016 it raised $6m in a Series B financing to support international expansion. The funding underscores the company’s focus on growing its geographic footprint while continuing to develop its core programmatic and retargeting product offering. Admedo is a London-based business that enables advertisers and agencies to manage their programmatic advertising in-house through a SaaS self-serve ad platform. The platform offers a full range of licensing options, from a free subscription for newcomers to a white-label solution for agencies. The company is led by CEO and founder Nick Moutter, with Steve Brown appointed as chairman. Admedo raised $2M in a Series A to support its growth. The funds are earmarked to accelerate product development, grow the development team, expand into new global markets, and grow the business. The company intends to use the injection to scale both product and market reach. Adizio operates a self-serve local advertising platform that lets brands and advertisers create and manage media buying online and target audiences efficiently. The platform also enables smaller brands to create online and mobile campaigns and purchase advertising space. The company was established in 2012 by Nick Moutter. Adizio is headquartered at the Staffordshire Technology Park in Stafford, UK. In February 2013 the company raised £250k in funding to support its business.